Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

AbbVie (NY: ABBV )

192.87 -0.58 (-0.30%)
Official Closing Price Updated: 7:00 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,976,906
Open 193.95
Bid (Size) 192.60 (1)
Ask (Size) 193.89 (10)
Prev. Close 193.45
Today's Range 192.78 - 195.18
52wk Range 153.58 - 207.32
Shares Outstanding N/A
Dividend Yield 3.21%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Is AbbVie Stock a Buy Now?
Via The Motley Fool
Why Is Nano-Cap Cancer-Focused Xilio Therapeutics Stock Trading Over 100% On Wednesday?
AbbVie and Xilio partner to develop tumor-activated immunotherapies. Xilio's pipeline includes masked T cell engagers for prostate, gastric, and lung cancers. 
Via Benzinga

Performance

YTD
+7.48%
+7.48%
1 Month
+11.04%
+11.04%
3 Month
+15.99%
+15.99%
6 Month
-2.03%
-2.03%
1 Year
+8.67%
+8.67%

More News

Read More
AbbVie and Xilio Therapeutics Announce Collaboration and Option Agreement to Develop Novel Tumor-Activated Immunotherapies
From Xilio Therapeutics, Inc.; AbbVie Inc.
Via GlobeNewswire
Biogen (BIIB) Reports Earnings Tomorrow: What To Expect
Via StockStory
Healthcare And Biotech Playbook As Disruption Gathers Force
Via Talk Markets
Topics ETFs Stocks / Equities
Looking At AbbVie's Recent Unusual Options Activity
Via Benzinga
These Stocks Missed on Earnings, But Will Rebound Next Quarter
Via MarketBeat
Gilead Sciences (GILD) Q4 Earnings: What To Expect
Via StockStory
3 Fabulous Dividend Stocks to Buy in February
Via The Motley Fool
Vertex Pharmaceuticals (VRTX) Q4 Earnings Report Preview: What To Look For
Via StockStory
Earnings To Watch: Incyte (INCY) Reports Q4 Results Tomorrow
Via StockStory
3 Dividend Stocks to Double Up on Right Now
Via The Motley Fool
These 2 Dividend Stocks Are Absolute Bargains Right Now
Via The Motley Fool
3 Top AI-Powered Biotech Stocks to Buy in February
Via The Motley Fool
Jim Cramer: This Health Care Stock Is A 'Winner,' Buy Bitcoin Instead Of Coinbase
Via Benzinga
Exploring the top movers within the S&P500 index during today's session.
Via Chartmill
Can Biotech Stocks Survive The Precarious Macro?
Via Talk Markets
Topics Stocks / Equities World Trade
Exposures Tariff
Top S&P500 movers in Monday's session
Via Chartmill
Nike To Rally Around 24%? Here Are 10 Top Analyst Forecasts For Monday
Via Benzinga
What You Missed On Friday
Via Talk Markets
Topics Stocks / Equities
U.S. Equity Rally Reverses As White House Confirms Imminent Tariffs, Shifting Focus To Fed Policy
Via Talk Markets
Topics Commodities Economy Futures
Exposures Interest Rates Tariff
Small- To Mid-Cap Biotech Trades Poised For Gains
Via Talk Markets
Topics ETFs Stocks / Equities
Want $1 Million in Retirement? 2 Stocks to Buy Now and Hold for Decades.
Via The Motley Fool
What's going on in today's session: S&P500 movers
Via Chartmill
AbbVie (NYSE:ABBV) Posts Better-Than-Expected Sales In Q4, Stock Soars
Via StockStory
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.